DOT1L promotes cell proliferation and invasion by epigenetically regulating STAT5B in renal cell carcinoma: Am J Cancer Res. 2023; 13(1): 276-292
American Journal of Cancer Research · 2026 · 16 (8) · 3746-3747
DOI: 10.62347/aiyl3323 ↗Kurz gefasst
Korrektur in der Zeitschrift American Journal of Cancer Research, 2026. Verfasst von Yanguang Hou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Renmin Hospital of Wuhan University Wuhan 430060, Hubei, PR China. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Urology, Renmin Hospital of Wuhan University Wuhan 430060, Hubei, PR China.
- Wuhan University Institute of Urologic Disease, Renmin Hospital of Wuhan University Wuhan 430060, Hubei, PR China.
Zitieren
APA
Hou, Y., Huang, S., Liu, J., Wang, L., Yuan, Y., Liu, H., Weng, X., Chen, Z., Hu, J., & Liu, X. (2026). DOT1L promotes cell proliferation and invasion by epigenetically regulating STAT5B in renal cell carcinoma: Am J Cancer Res. 2023; 13(1): 276-292. American Journal of Cancer Research, 16(8), 3746-3747. https://doi.org/10.62347/aiyl3323
Vancouver
Hou Y, Huang S, Liu J, Wang L, Yuan Y, Liu H, et al. DOT1L promotes cell proliferation and invasion by epigenetically regulating STAT5B in renal cell carcinoma: Am J Cancer Res. 2023; 13(1): 276-292. American Journal of Cancer Research. 2026;16(8):3746-3747. doi:10.62347/aiyl3323
BibTeX
@article{Hou2026,
author = {Hou, Yanguang and Huang, Shiyu and Liu, Jiachen and Wang, Lei and Yuan, Yan and Liu, Hao and Weng, Xiaodong and Chen, Zhiyuan and Hu, Juncheng and Liu, Xiuheng},
title = {DOT1L promotes cell proliferation and invasion by epigenetically regulating STAT5B in renal cell carcinoma: Am J Cancer Res. 2023; 13(1): 276-292},
journal = {American Journal of Cancer Research},
year = {2026},
volume = {16},
number = {8},
pages = {3746--3747},
doi = {10.62347/aiyl3323}
}
EUVIMED